Tianzhu Wang Selected Research

Platelet Aggregation Inhibitors (Antiplatelet Drugs)

1/2020

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tianzhu Wang Research Topics

Disease

1	Neoplasms (Cancer) 03/2023
1	Relapsing-Remitting Multiple Sclerosis 01/2021
1	Multiple System Atrophy 01/2021
1	Cerebellar Ataxia (Dysmetria) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Multiple Sclerosis 01/2021
1	Moyamoya Disease (Moya-Moya Disease) 01/2020
1	Inflammation (Inflammations) 01/2015
1	Vascular Remodeling 01/2015
1	Cerebral Hemorrhage 01/2011
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2011
1	Hydrocephalus (Hydrocephaly) 01/2011
1	Hyperglycemia 01/2011
1	Spasm (Spasms) 01/2011
1	Intracranial Hypertension 01/2011
1	Hemorrhage 01/2011
1	Stroke (Strokes) 11/2010
1	Brain Ischemia (Cerebral Ischemia) 11/2010

Drug/Important Bio-Agent (IBA)

1	Coloring Agents (Dyes)IBA 03/2023
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	N-methyladenosineIBA 01/2021
1	Cystatin CIBA 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	CytokinesIBA 01/2015
1	Telmisartan (Micardis)FDA Link 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	ElectrolytesIBA 01/2011
1	Blood Glucose (Blood Sugar)IBA 01/2011
1	H 189IBA 01/2011
1	Messenger RNA (mRNA)IBA 11/2010
1	Nogo ReceptorsIBA 11/2010
1	Proteins (Proteins, Gene)FDA Link 11/2010